United Kingdom

Sanofi to acquire UK-Based Vaccine Biotech Vicebio in €1.36B Deal
Paris-headquartered pharmaceutical company Sanofi has announced its intention to acquire British biotech firm Vicebio in a deal worth up to €1.36 billion.

The best Articles in our Network

Previous
Next